Overview

Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake

Status:
Terminated

Trial end date:
2017-07-01

Target enrollment:

Participant gender:

Summary

The primary objective is to determine if subjects taking the natural product AphoelineBrake™ in addition to their standard treatment experience differences in metabolic disease control, gastrointestinal hormones and inflammatory markers diet, hunger, satiety, weight, compared to patients taking a placebo in addition to their standard treatment. The secondary objective is to study the effect of Aphoeline Brake on oxidative and inflammatory stress markers.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Dasman Diabetes Institute

Collaborator:

University at Buffalo